Their ability to enhance thermogenesis, improve insulin sensitivity, and influence lipid metabolism makes them promising targets for therapeutic interventions in obesity and metabolic disorders. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.